GART expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.970600E-01
Normal-vs-Stage2
9.344800E-01
Normal-vs-Stage3
2.197800E-01
Normal-vs-Stage4
9.327000E-01
Stage1-vs-Stage2
7.934000E-01
Stage1-vs-Stage3
2.325600E-01
Stage1-vs-Stage4
8.307200E-01
Stage2-vs-Stage3
1.606250E-01
Stage2-vs-Stage4
9.751600E-01
Stage3-vs-Stage4
1.739400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.313600E-01
Normal-vs-AfricanAmerican
7.712000E-01
Normal-vs-Asian
8.682000E-01
Caucasian-vs-AfricanAmerican
5.946400E-01
Caucasian-vs-Asian
9.066200E-01
AfricanAmerican-vs-Asian
5.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.820800E-01
Normal-vs-Female
9.015600E-01
Male-vs-Female
7.145400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.376600E-01
Normal-vs-Age(41-60Yrs)
8.028200E-01
Normal-vs-Age(61-80Yrs)
7.848800E-01
Normal-vs-Age(81-100Yrs)
7.425000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.120600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.075800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.665200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.595700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.722200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.972220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.827000E-01
Normal-vs-Daily Drinker
6.438400E-01
Normal-vs-Weekly Drinker
8.835400E-01
Normal-vs-Occasional Drinker
9.325000E-01
Normal-vs-Social Drinker
9.601600E-01
Non Drinker-vs-Daily Drinker
3.539200E-01
Non Drinker-vs-Weekly Drinker
8.401400E-01
Non Drinker-vs-Occasional Drinker
9.470400E-01
Non Drinker-vs-Social Drinker
9.725400E-01
Daily Drinker-vs-Weekly Drinker
5.375400E-01
Daily Drinker-vs-Occasional Drinker
3.223400E-01
Daily Drinker-vs-Social Drinker
4.102800E-01
Weekly Drinker-vs-Occasional Drinker
8.466600E-01
Weekly Drinker-vs-Social Drinker
8.607600E-01
Occasional Drinker-vs-Social Drinker
9.831000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.666200E-01
Normal-vs-Grade 2
5.492200E-02
Normal-vs-Grade 3
4.247900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.315700E-03
Grade 1-vs-Grade 3
6.359300E-04
Grade 1-vs-Grade 4
3.666200E-01
Grade 2-vs-Grade 3
2.151400E-01
Grade 2-vs-Grade 4
5.492200E-02
Grade 3-vs-Grade 4
4.247900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.835400E-01
Normal-vs-NonDiabetic
8.507800E-01
Diabetic-vs-NonDiabetic
4.632400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.541600E-01
Normal-vs-NoPancreatitis
8.019800E-01
Pancreatitis-vs-NoPancreatitis
4.270600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.392600E-01
Normal-vs-N1
9.778800E-01
N0-vs-N1
4.625600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.477400E-01
Normal-vs-TP53-NonMutant
9.098600E-01
TP53-Mutant-vs-TP53-NonMutant
3.658800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
